Efficiency of Combining Trastuzumab with Chemotherapy in case of advanced gastric carcinoma with low level amplification HER2 (c-erb-B2 protein)

Gastric cancer is the second most common cause of cancer death in the world, although its incidence is declining over the last decades. Several factors of modern medicine have improved the management of gastric cancer. There has often been a poor prognosis because once symptoms occur, gastric cancer is often advanced. However, the multidisciplinary approach of gastric cancer therapy and adjuvant therapy are a promising management treatment.1